Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
adrenal, alpha, Anderson, Asia, baseline, body, Brown, CAD, Canadian, cerebrospinal, CNS, commensurate, consecutive, corticosteroid, diagnosed, Eastern, endometrial, endpoint, expeditiously, explored, fluid, free, function, hematological, HGG, HSR, IDMC, installment, intrinsic, Karnofsky, Lansky, leptomeningeal, listed, MD, modest, NANO, neurologic, OS, Pacific, pancreatic, paragraph, PFS, PHAC, placebo, PNOC, pontine, Premerger, presence, pulmonary, QoL, RANO, reclassified, refiling, resubmitted, Secondary, shortly, solid, spinal, Stratification, tumor, USD, week, weight, withdrew
Removed:
end, forecasting, informed, reassessment
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view